Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro

PURPOSE: Osteoarthritis (OA) is a prevalent, progressively degenerative disease. Researchers have rigorously documented clinical improvement in participants receiving prolotherapy for OA. The mechanism of action is unknown; therefore, basic science studies are required. One hypothesized mechanism is...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Exp Orthop
Glavni autori: Johnston, Elisha, Emani, Chandrakanth, Kochan, Andrew, Ghebrehawariat, Kidane, Tyburski, John, Johnston, Michael, Rabago, David
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2020
Teme:
Original Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7719583/
https://ncbi.nlm.nih.gov/pubmed/33280075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40634-020-00312-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items